We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...
US food tech startup The Every Company has raised $55M in Series D funding to expand its precision-fermented egg proteins, ...
Colossal Biosciences, which has brought to life a small pack of genetically modified dire wolves, has acquired cloning ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...
13hon MSN
Molecular dynamics simulations use atomistic force field to capture RNA folding with high accuracy
Ribonucleic acid (RNA) is one of life's most versatile molecules, with roles going far beyond being a messenger of genetic ...
Michael Buck, PhD, professor of biochemistry in the Jacobs School, recently received NIH funding to explore how molecular readers of DNA access and activate seemingly hidden genes.
Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and ...
To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback